A clinical trial of dextromethorphan in amyotrophic lateral sclerosis
Introduction - Although the cause of amyotrophic lateral sclerosis (ALS) is unknown, excitotoxicity mediated by glutamate has been implicated. Dextromethorphan is a NMDA-glutamate receptor antagonist with neuroprotective properties. Material and methods - The effect of treatment with dextromethorpha...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , |
---|---|
Format: | Artigo |
Langue: | anglais |
Publié: |
2009
|
Accès en ligne: | https://doi.org/10.1111/j.1600-0404.1997.tb00231.x |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|